J Jueckstock

892 total citations
31 papers, 374 citations indexed

About

J Jueckstock is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Jueckstock has authored 31 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Jueckstock's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (10 papers) and Cervical Cancer and HPV Research (8 papers). J Jueckstock is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (10 papers) and Cervical Cancer and HPV Research (8 papers). J Jueckstock collaborates with scholars based in Germany, Netherlands and France. J Jueckstock's co-authors include Sven� Mahner, Udo Jeschke, Brigitte Rack, Ulrich Andergassen, Sophie Fuerst, Philipp Harter, Linn Woelber, Nikolaus de Gregorio, Peter Hillemanns and Felix Hilpert and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

J Jueckstock

29 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Jueckstock Germany	9	163	139	117	109	96	31	374
David Shimizu United States	11	135 0.8×	162 1.2×	137 1.2×	133 1.2×	71 0.7×	26	450
Victòria Fusté Spain	9	90 0.6×	62 0.4×	249 2.1×	244 2.2×	92 1.0×	12	420
Lucía González‐Cortijo Spain	11	108 0.7×	192 1.4×	59 0.5×	94 0.9×	80 0.8×	26	434
Ayumi Shikama Japan	11	90 0.6×	146 1.1×	48 0.4×	33 0.3×	73 0.8×	33	318
Sérgio A. Triginelli Brazil	11	73 0.4×	203 1.5×	113 1.0×	127 1.2×	36 0.4×	27	351
Sambor Sawicki Poland	12	55 0.3×	188 1.4×	118 1.0×	95 0.9×	47 0.5×	44	393
Takeo Otsuki Japan	11	161 1.0×	205 1.5×	169 1.4×	102 0.9×	22 0.2×	21	429
Sang‐Young Ryu South Korea	10	106 0.7×	280 2.0×	141 1.2×	117 1.1×	24 0.3×	21	440
Kohei Omatsu Japan	13	123 0.8×	337 2.4×	82 0.7×	126 1.2×	41 0.4×	61	561
Maki Matoda Japan	12	78 0.5×	307 2.2×	143 1.2×	123 1.1×	34 0.4×	48	464

Countries citing papers authored by J Jueckstock

Since Specialization

Citations

This map shows the geographic impact of J Jueckstock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Jueckstock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Jueckstock more than expected).

Fields of papers citing papers by J Jueckstock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Jueckstock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Jueckstock. The network helps show where J Jueckstock may publish in the future.

Co-authorship network of co-authors of J Jueckstock

This figure shows the co-authorship network connecting the top 25 collaborators of J Jueckstock. A scholar is included among the top collaborators of J Jueckstock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Jueckstock. J Jueckstock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jueckstock, J, Aurelia Vattai, Helene Hildegard Heidegger, et al.. (2023). MTA1 as negative prognostic marker in vulvar carcinoma. Journal of Cancer Research and Clinical Oncology. 149(9). 6191–6201. 1 indexed citations

Woelber, Linn, Mareike Bommert, Philipp Harter, et al.. (2021). Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study. Annals of Surgical Oncology. 28(11). 6696–6704. 2 indexed citations

Prieske, Katharina, Linn Woelber, Mustafa Zelal Muallem, et al.. (2021). Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study. Gynecologic Oncology. 161(2). 442–448. 11 indexed citations

Prieske, Katharina, Linn Woelber, Mustafa Zelal Muallem, et al.. (2020). Evaluation of treatment patterns and prognosis in correlation with age in patients with vulvar cancer: A subset analysis of the AGO-CaRE-1 study.. Journal of Clinical Oncology. 38(15_suppl). 6090–6090.

Woelber, Linn, Katharina Prieske, Christine zu Eulenburg, et al.. (2019). p53 and p16 expression profiles reveal three prognostically relevant subgroups in vulvar cancer: A TMA based study by the AGO-CaRE-translational study group.. Journal of Clinical Oncology. 37(15_suppl). 5592–5592. 6 indexed citations

Jueckstock, J, Brigitte Rack, Thomas W. P. Friedl, et al.. (2016). Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial. BMC Cancer. 16(1). 401–401. 14 indexed citations

Woelber, Linn, Christine zu Eulenburg, Petra Neuser, et al.. (2016). Prognosis after local recurrence in vulvar cancer: A subset analysis of the AGO-CaRE-1 study.. Journal of Clinical Oncology. 34(15_suppl). 5595–5595.

Janni, Wolfgang, Nadia Harbeck, Brigitte Rack, et al.. (2016). Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study. British Journal of Cancer. 114(8). 863–871. 10 indexed citations

Andergassen, Ulrich, et al.. (2016). Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets. Journal of Cancer Research and Clinical Oncology. 142(9). 1883–1895. 20 indexed citations

10.

Jueckstock, J, et al.. (2015). Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis. Archives of Gynecology and Obstetrics. 292(5). 1101–1107. 8 indexed citations

11.

Mahner, Sven�, J Jueckstock, Felix Hilpert, et al.. (2015). Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study. JNCI Journal of the National Cancer Institute. 107(3). 128 indexed citations

12.

Janni, Wolfgang, Andreas Schneeweiß, Lothar Haeberle, et al.. (2014). Adjuvant gemcitabine for high-risk breast cancer (BC) patients: Final survival results of the randomized phase III SUCCESS-A study.. Journal of Clinical Oncology. 32(15_suppl). 1010–1010. 4 indexed citations

13.

Neugebauer, Julia, Ulrich Andergassen, Bernadette Jaeger, et al.. (2013). Evaluation of prevalence, number, and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in the SUCCESS A study.. Journal of Clinical Oncology. 31(15_suppl). 11042–11042. 2 indexed citations

14.

Mahner, Sven�, J Jueckstock, Felix Hilpert, et al.. (2012). Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study.. Journal of Clinical Oncology. 30(15_suppl). 5007–5007. 4 indexed citations

15.

Harbeck, Nadia, H. Sommer, Doris Augustin, et al.. (2011). PD07-01: Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120 in the Adjuvant Treatment of Breast Cancer Patients with Extensive Lymph Node Involvement: Final Survival Analysis of the German ADEBAR Phase III Study.. Cancer Research. 71(24_Supplement). PD07–1. 1 indexed citations

16.

Schindlbeck, Christian, Doris Mayr, Camille Olivier, et al.. (2010). Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer. Journal of Cancer Research and Clinical Oncology. 136(7). 1029–1037. 29 indexed citations

17.

Schindlbeck, Christian, J Jueckstock, Andreas Schneeweiß, et al.. (2009). Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.. Cancer Research. 69(2_Supplement). 303–303. 4 indexed citations

18.

Janni, W, Nadia Harbeck, Brigitte Rack, et al.. (2007). Final toxicity analysis of the ADEBAR phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement. mediaTUM (Technical University of Munich). 1 indexed citations

19.

Jueckstock, J, Ioannis Mylonas, B. Strobl, et al.. (2007). Paravasation with Cyclophosphamide – Case Report of Tissue Necrosis in a Patient with Primary Breast Cancer. Oncology Research and Treatment. 30(8-9). 452–454. 7 indexed citations

20.

Janni, W, Gro Wiedswang, Tanja Fehm, et al.. (2006). Persistence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse—Results of pooled European data. Journal of Clinical Oncology. 24(18_suppl). 10083–10083. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact